feed,title,long_url,short_url
Benzinga,"First Head & Neck Cancer Patient Treated in France in a Phase I Trial With TG4050 (myvacÂ® Platform), Transgene's Innovative Individualized Immunotherapy",https://www.benzinga.com/pressreleases/21/01/b19248273/first-head-neck-cancer-patient-treated-in-france-in-a-phase-i-trial-with-tg4050-myvac-platform-tra,https://j.mp/3o5GJMF
